We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SOPH market cap is 300.71M. The company's latest EPS is USD -1.1295 and P/E is -4.10.
Quarter End | |
---|---|
USD ($) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2021 | 2021 |
---|---|
USD ($) | |
Total Revenue | 40.45M |
Operating Income | -71.49M |
Net Income | -73.68M |
Quarter End | |
---|---|
USD ($) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2021 | 2021 |
---|---|
USD ($) | |
Total Assets | 320.17M |
Total Liabilities | 44.77M |
Total Equity | 275.4M |
Market Cap | 300.71M |
Price to Earnings Ratio | -4.10 |
Price to Sales Ratio | 7.47 |
Price to Cash Ratio | 1.57 |
Price to Book Ratio | 1.1 |
Dividend Yield | - |
Shares Outstanding | 65.23M |
Average Volume (1 week) | 90.48k |
Average Volume (1 Month) | 76.84k |
52 Week Change | 2.90% |
52 Week High | 7.37 |
52 Week Low | 2.13 |
Spread (Intraday) | 3.32 (44.74%) |
Company Name | Sophia Genetics SA |
Address |
rue du centre 172 lausanne 1025 |
Website | https://www.sophiagenetics.com |
Industry | cmp processing,data prep svc (7374) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions